Lortab and Ejection fraction abnormal - a phase IV clinical study of FDA data

Summary:

Ejection fraction abnormal is found among people who take Lortab, especially for people who are 60+ old.

The phase IV clinical study analyzes which people take Lortab and have Ejection fraction abnormal. It is created by eHealthMe based on reports of 29,018 people who have side effects when taking Lortab from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

29,018 people reported to have side effects when taking Lortab.
Among them, 12 people (0.04%) have Ejection fraction abnormal.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 30,752 Lortab users for its effectiveness, alternative drugs and more.

What is Ejection fraction abnormal?

Ejection fraction abnormal (abnormality in percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat) is found to be associated with 923 drugs and 296 conditions by eHealthMe.

Number of Lortab and Ejection fraction abnormal reports submitted per year:

$Could Lortab cause Ejection fraction abnormal?$

Age of people who have Ejection fraction abnormal when taking Lortab *:

Common drugs people take besides Lortab *:

Common side effects people have besides Ejection fraction abnormal *:

Mitral Valve Incompetence (inefficient heart valve): 4 people, 33.33%
Breathing Difficulty: 4 people, 33.33%
Cardiac Failure Congestive: 4 people, 33.33%
Joint Pain: 4 people, 33.33%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 25.00%
Cardiomyopathy (weakening of the heart muscle): 3 people, 25.00%
Chest Pain: 3 people, 25.00%
Fever: 3 people, 25.00%
Injury: 3 people, 25.00%
Abdominal Pain: 3 people, 25.00%

Common conditions people have *:

Irritable Bowel Syndrome: 2 people, 16.67%
Prostate Cancer: 1 person, 8.33%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 8.33%
Depression: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lortab and have Ejection fraction abnormal?

Check whether Ejection fraction abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Ejection fraction abnormal and when was it recovered:

Ejection fraction abnormal in Lortab

Expand to all the drugs that have ingredients of acetaminophen; hydrocodone bitartrate:

Ejection fraction abnormal and drugs with ingredients of acetaminophen; hydrocodone bitartrate (52 reports)

Alternative drugs to, pros and cons of Lortab:

Lortab (30,752 reports)

Common Lortab side effects:

Pain: 4,969 reports
Stress and anxiety: 2,873 reports
Fatigue (feeling of tiredness): 2,236 reports
Breathing difficulty: 2,174 reports

Browse all side effects of Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ejection fraction abnormal treatments and more:

Ejection fraction abnormal (2,808 reports)

COVID vaccines that are related to Ejection fraction abnormal:

Common drugs associated with Ejection fraction abnormal:

All the drugs that are associated with Ejection fraction abnormal:

Ejection fraction abnormal (923 drugs)

All the conditions that are associated with Ejection fraction abnormal:

Ejection fraction abnormal (296 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate (the active ingredients of Lortab) and Lortab (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.